Pfizer

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE182A01018
  • NSEID: PFIZER
  • BSEID: 500680
INR
4,613.50
-112.4 (-2.38%)
BSENSE

May 13

BSE+NSE Vol: 36.11 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Acutaas Chemical
Sai Life
Neuland Labs.
Natco Pharma
ERIS Lifescience
Wockhardt
Astrazeneca Phar
Piramal Pharma
Pfizer
OneSource Speci.
Cohance Life

Why is Pfizer Ltd. ?

1
Poor long term growth as Net Sales has grown by an annual rate of 2.39% and Operating profit at 7.42% over the last 5 years
2
Flat results in Mar 26
3
With ROE of 19.7, it has a Very Expensive valuation with a 5.5 Price to Book Value
  • The stock is trading at a fair value compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 6.53%, its profits have risen by 19.8% ; the PEG ratio of the company is 1.4
  • At the current price, the company has a high dividend yield of 3.6
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Pfizer for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
Pfizer
6.7%
0.25
27.07%
Sensex
-8.06%
-0.61
13.15%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
2.39%
EBIT Growth (5y)
7.42%
EBIT to Interest (avg)
65.70
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.69
Sales to Capital Employed (avg)
0.74
Tax Ratio
25.96%
Dividend Payout Ratio
119.20%
Pledged Shares
0
Institutional Holding
19.71%
ROCE (avg)
49.32%
ROE (avg)
18.68%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
28
Industry P/E
34
Price to Book Value
5.48
EV to EBIT
21.75
EV to EBITDA
20.37
EV to Capital Employed
15.51
EV to Sales
7.31
PEG Ratio
1.40
Dividend Yield
3.58%
ROCE (Latest)
63.46%
ROE (Latest)
19.72%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
PBDIT(Q)

Highest at Rs 235.95 cr.

PBT LESS OI(Q)

Highest at Rs 219.06 cr.

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...

Here's what is working for Pfizer

Operating Profit (PBDIT) - Quarterly
Highest at Rs 235.95 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 219.06 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)